Publications by authors named "Liding Bai"

Claim this Profile
S
Salvianolic acid A reduces lipotoxicity injury of cardiomyocytes by orchestrating oxidative stress and inflammation via Akt/Nrf2/NF-κB axis.
Lin Li, Siqi Du, Xianghui Meng, Liding Bai, Danni Huang

J Mol Histol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lingguizhugan decoction inhibits the cleavage of LYVE-1 by MMP-9 and promotes lymphangiogenesis to improve myocardial infarction.
Liding Bai, Jiaxin Li, Siqi Du, Wei Lei, Fengjie Zhou

Phytomedicine· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sanye tablet regulates gut microbiota and bile acid metabolism to attenuate hepatic steatosis.
Yulin Qi, Siqi Du, Wenwen Li, Xianzhe Qiu, Fengjie Zhou, Liding Bai

J Ethnopharmacol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycyrrhiza polysaccharides may have an antitumor effect in γδT cells through gut microbiota and TLRs/NF-κB pathway in mice.
Yinxiao Chen, Zhaodong Li, Liding Bai, Bin Lu, Yanfei Peng

FEBS Open Bio· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphangiogenesis: A new strategy for heart disease treatment (Review).
Liding Bai, Yanyan Wang, Siqi Du, Yumeng Si, Lu Chen

Int J Mol Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intestinal flora: New perspective of type 2 diabetes.
Yan Liu, Jun Chang, Li-Ding Bai

World J Clin Cases· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases (Review).
Xiaolu Zhang, Ziyu Wang, Yujia Zheng, Qun Yu, Miao Zeng, Liding Bai

Int J Mol Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-inflammatory activity of the Tongmai Yangxin pill in the treatment of coronary heart disease is associated with estrogen receptor and NF-κB signaling pathway.
Yadong Fan, Jianwei Liu, Jing Miao, Xiaoyu Zhang, Yiqi Yan, Liding Bai

J Ethnopharmacol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis